Thrombin Stimulates Human Endothelial Arginase Enzymatic Activity via RhoA/ROCK Pathway

Authors:

Abstract
Background— Arginase competes with endothelial nitric oxide synthase (eNOS) for the substrate l -arginine and decreases NO production. This study investigated regulatory mechanisms of arginase activity in endothelial cells and its role in atherosclerosis. Methods and Results— In human endothelial cells isolated from umbilical veins, thrombin concentration- and time-dependently stimulated arginase enzymatic activity, reaching a 1.9-fold increase ( P P −/− compared with wild-type mice. Interestingly, l -arginine (1 mmol/L), despite a significantly higher eNOS expression in aortas of apoE −/− mice, evoked a more pronounced contraction, which was reverted to a greater vasodilation by the arginase inhibitor l -norvaline (20 mmol/L) compared with the wild-type animals (n=5, P Conclusions— Thrombin enhances arginase activity via RhoA/ROCK in human endothelial cells. Higher arginase enzymatic activity is involved in atherosclerotic endothelial dysfunction in apoE −/− mice. Targeting vascular arginase may represent a novel therapeutic possibility for atherosclerosis.

This publication has 25 references indexed in Scilit: